Fig. 3From: Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogressionThyroid SUVMax % Δ Post SSA (n = 21)Back to article page